STAT+: Why is Eli Lilly worth nearly $1 trillion?

Eli Lilly's near $1 trillion valuation signifies unparalleled investor confidence in its GLP-1 drugs, positioning it as the leading pharmaceutical company globally. This milestone showcases the market potential and commercial success of innovative drug development, setting a high bar for competitors and highlighting the significance of GLP-1 therapies in the industry.